Key result
Nanomechanical analysis of cell-derived matrices revealed differences in elastic modulus across COL6-RD clinical phenotypes and demonstrated restoration of elasticity following genetic editing.
Why the study?
No direct correlation exists between the genotype and phenotype of collagen VI-related congenital muscular dystrophies, prompting evaluation of cell-derived matrix nanomechanics as a functional read-out.
Does nanomechanical analysis of cell-derived matrices differentiate clinical phenotypes and reflect response to gene therapy in collagen VI-related congenital muscular dystrophies?
Does nanomechanical analysis of cell-derived matrices differentiate clinical phenotypes and reflect response to gene therapy in collagen VI-related congenital muscular dystrophies?
Nanomechanical analysis of cell-derived matrices can serve as a functional read-out for phenotypic categorization and response to gene therapy in collagen VI-related congenital muscular dystrophies.
Changes in the mechanical properties of the extracellular matrix (ECM) are a hallmark of disease. Due to its relevance, several in vitro models have been developed for the ECM, including cell-derived matrices (CDMs). CDMs are decellularized natural ECMs assembled by cells that closely mimic the in vivo stromal fibre organization and molecular content. Here, we applied atomic force microscopy-force spectroscopy (AFM-FS) to evaluate the nanomechanical properties of CDMs obtained from patients diagnosed with collagen VI-related congenital muscular dystrophies (COL6-RDs). COL6-RDs are a set of neuromuscular conditions caused by pathogenic variants in any of the three major COL6 genes, which result in deficiency or dysfunction of the COL6 incorporated into the ECM of connective tissues. Current diagnosis includes the genetic confirmation of the disease and categorization of the phenotype based on maximum motor ability, as no direct correlation exists between genotype and phenotype of COL6-RDs. We describe differences in the elastic modulus ( E ) among CDMs from patients with different clinical phenotypes, as well as the restoration of E in CDMs obtained from genetically edited cells. Results anticipate the potential of the nanomechanical analysis of CDMs as a complementary clinical tool, providing phenotypic information about COL6-RDs and their response to gene therapies.
No takes yet. Share an insight, caveat, or question.
White et al. (2025) studied Collagen VI-related congenital muscular dystrophies (COL6-RDs). Nanomechanical analysis of cell-derived matrices (CDMs) using atomic force microscopy-force spectroscopy vs. CDMs from different clinical phenotypes and genetically edited cells was evaluated on Elastic modulus (E) of cell-derived matrices. Nanomechanical analysis of cell-derived matrices revealed differences in elastic modulus across COL6-RD clinical phenotypes and demonstrated restoration of elasticity following genetic editing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: